ImmunityBio, Inc. — Director's Dealing 2018

Aug 28, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NantKwest, Inc. (NK)
CIK: 0001326110
Period of Report: 2018-08-23

Reporting Person: GORLIN STEVE (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-08-23	Common Stock	S	21475	$3.0598	Disposed	224805	Direct
2018-08-24	Common Stock	S	10225	$3.0651	Disposed	214580	Direct
2018-08-27	Common Stock	S	18300	$3.0854	Disposed	196280	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	321720	Indirect

Footnotes

F1: Represents the weighted average share price of an aggregate total of 21,475 shares sold in the price range of $3.03 to $3.105 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2: Represents the weighted average share price of an aggregate total of 10,225 shares sold in the price range of $3.04 to $3.11 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Represents the weighted average share price of an aggregate total of 18,300 shares sold in the price range of $3.05 to $3.14 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.